PMP2
protein-codingperipheral myelin protein 2, the group of Fatty acid binding protein family
Gene summary
The protein encoded by this gene localizes to myelin sheaths of the peripheral nervous system. The encoded protein can bind both the membrane layers of the sheaths and monomeric lipids, and is thought to provide stability to the sheath. A defect in this gene was shown to be a cause of dominant demyelinating CMT neuropathy. [provided by RefSeq, Jan 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0033135
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0033135
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0015626
Submitter: ClinGen
PMP2 was first reported in relation to autosomal dominant Charcot-Marie-Tooth Disease in 2015 (Gonzaga-Jauregui et al., PMID: 26257172). At least six variants (e.g. missense, in-frame indel) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, limited segregation data, and experimental data. Variants in this gene have been reported in at least nine probands in seven publications (PMIDs: 26257172, 27009151, 30249361, 31412900, 26828946, 32277537, 37238449). Variants in this gene segregated with disease in several additional family members, including a large multi-generational family (37238449). There is variant level experimental evidence to support pathogenicity of 6 of the reported variants (PMID: 28747762, 34138518). In total, genetic evidence totals 4.5 points. The mechanism for disease is suspected to be a monoallelic gain-of-function or dominant negative effect with variants affecting the myelin structure or causing upregulation of the protein (PMID: 28747762). This gene-disease association is additionally supported by PMP2's function in lipid homeostasis and remyelination, as well as functional evidence in PMP2 null mice. Expression of PMP2 in myelin, interacting with MPZ, a protein also associated with demyelinating CMT, also provides evidence towards its pathogenicity. A transgenic mouse model expressing the I43N variant does recapitulate many of the phenotypes observed in humans. However, the possibility for interference via overexpression, rather than from the variant itself, requires more clarification in future studies. In total, experimental evidence totals 2.5. In summary, there is moderate evidence to support this gene-disease relationship with a total of 7 points. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged.
Inheritance Pattern: AD
Disease ID:MONDO:0033135
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0033135
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PMP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002677.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 15 | 18 | |||
| missense | 1 | 6 | 55 | 6 | 4 | 72 |
| nonsense | 3 | 3 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 4 | 4 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 6 | 66 | 21 | 4 | 98 |
Highest pathogenic variant AF is 6.8421355e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002668.1 | 4 | MANE Select | |
| Ensembl | ENSP00000256103.2 | 4 | MANE Select | |
| RefSeq | NP_001335310.1 | 3 | Standard | |
| Ensembl | ENSP00000429917.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glucocorticoid Receptor Pathway
- Nuclear Receptors Meta-Pathway
Biological Process
- membrane organization
Molecular Function
- fatty acid binding
- protein binding
- cholesterol binding
Cellular Component
- cytoplasm
- myelin sheath
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000256103
- Coding exons
- 4
- Length
- 7198
- Individuals with no LoFs
- 125722
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 8
- Defined
- 125730
- p
- 0.0000318
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0996 | 67 | 69.3 | 0.966 | 0.00000334 | 863 |
| Missense (PolyPhen) | 17 | 17.503 | 0.97127 | 247 | ||
| Synonymous | 0.554 | 22 | 25.6 | 0.861 | 0.00000135 | 241 |
| Loss of Function | 1.05 | 4 | 6.99 | 0.572 | 3.93e-7 | 82 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000026 | 0.000026 | rare |
| South Asian | 0.000036 | 0.000033 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May play a role in lipid transport protein in Schwann cells. May bind cholesterol. {ECO:0000269|PubMed:20421974}.;
Recessive Scores
- pRec
- 0.364
Intolerance Scores
- LoFtool
- 0.585
- RVIS EVS
- 0.55
- RVIS percentile EVS
- 81.22
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.262
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |